cis-(+/-)-2-(8-Methoxy-1-methyl-5,10-dioxo-3,4,5,10-tetrahydro-1H-naphtho[2,3-c]pyran-3-yl)acetic acid

ID: ALA608117

Chembl Id: CHEMBL608117

PubChem CID: 45257209

Max Phase: Preclinical

Molecular Formula: C17H16O6

Molecular Weight: 316.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)C(=O)C1=C(C[C@H](CC(=O)O)O[C@@H]1C)C2=O

Standard InChI:  InChI=1S/C17H16O6/c1-8-15-13(6-10(23-8)7-14(18)19)16(20)11-4-3-9(22-2)5-12(11)17(15)21/h3-5,8,10H,6-7H2,1-2H3,(H,18,19)/t8-,10-/m1/s1

Standard InChI Key:  YOYHYPFUGDLGQZ-PSASIEDQSA-N

Associated Targets(Human)

TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Type-2 restriction enzyme XhoI (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 316.31Molecular Weight (Monoisotopic): 316.0947AlogP: 2.02#Rotatable Bonds: 3
Polar Surface Area: 89.90Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.57CX Basic pKa: CX LogP: 1.21CX LogD: -2.14
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.92Np Likeness Score: 1.19

References

1. Sperry J, Lorenzo-Castrillejo I, Brimble MA, Machín F..  (2009)  Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.,  17  (20): [PMID:19783445] [10.1016/j.bmc.2009.08.064]
2. Heapy AM, Patterson AV, Smaill JB, Jamieson SM, Guise CP, Sperry J, Hume PA, Rathwell K, Brimble MA..  (2013)  Synthesis and cytotoxicity of pyranonaphthoquinone natural product analogues under bioreductive conditions.,  21  (24): [PMID:24436995] [10.1016/j.bmc.2013.09.052]

Source